0000899243-16-012535.txt : 20160202
0000899243-16-012535.hdr.sgml : 20160202
20160202161545
ACCESSION NUMBER: 0000899243-16-012535
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160201
FILED AS OF DATE: 20160202
DATE AS OF CHANGE: 20160202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clovis Oncology, Inc.
CENTRAL INDEX KEY: 0001466301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900475355
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (303) 625-5000
MAIL ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hooks Corwin Dale
CENTRAL INDEX KEY: 0001665347
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35347
FILM NUMBER: 161381056
MAIL ADDRESS:
STREET 1: C/O CLOVIS ONCOLOGY, INC.
STREET 2: 5500 FLATIRON PARKWAY
CITY: BOULDER
STATE: CO
ZIP: 80301
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2016-02-01
0
0001466301
Clovis Oncology, Inc.
CLVS
0001665347
Hooks Corwin Dale
C/O CLOVIS ONCOLOGY, INC.
5500 FLATIRON PARKWAY
BOULDER
CO
80301
0
1
0
0
See remarks
Common Stock
703
D
Stock option (right to buy)
46.68
2024-08-25
Common Stock
50000
D
Stock option (right to buy)
79.05
2025-03-02
Common Stock
5600
D
The option vested as to 25% of the shares on August 25, 2015, and the remainder shall vest in substantially equal installments over the 36 months immediately following such date.
The option shall vest as to 25% of the shares on March 2, 2016, and the remainder shall vest in substantially equal installments over the 36 months immediately following such date.
Senior Vice President and Chief Commercial Officer
/s/ Corwin Dale Hooks
2016-02-01